Can Fite Biopharma
CANF
#10386
Rank
C$9.97 M
Marketcap
C$0.43
Share price
-7.67%
Change (1 day)
-80.64%
Change (1 year)

Annual Reports (20-F)

Latest form 20-F annual reports for Can Fite Biopharma CIK: 0001536196
The 20-F is a 10-K equivalent for non-US companies, as a foreight company Can Fite Biopharma only files 20-F reports

Thumbnail Can Fite Biopharma
 20-F Annual Report 2024

20-F Annual Report 2024

Language: English

View Annual Report (20-F)
Thumbnail Can Fite Biopharma
 20-F Annual Report 2023

20-F Annual Report 2023

Language: English

View Annual Report (20-F)
Thumbnail Can Fite Biopharma
 20-F Annual Report 2022

20-F Annual Report 2022

Language: English

View Annual Report (20-F)
Thumbnail Can Fite Biopharma
 20-F Annual Report 2021

20-F Annual Report 2021

Language: English

View Annual Report (20-F)
Thumbnail Can Fite Biopharma
 20-F Annual Report 2020

20-F Annual Report 2020

Language: English

View Annual Report (20-F)
Thumbnail Can Fite Biopharma
 20-F Annual Report 2019

20-F Annual Report 2019

Language: English

View Annual Report (20-F)
Thumbnail Can Fite Biopharma
 20-F Annual Report 2018

20-F Annual Report 2018

Language: English

View Annual Report (20-F)
Thumbnail Can Fite Biopharma
 20-F Annual Report 2017

20-F Annual Report 2017

Language: English

View Annual Report (20-F)
Thumbnail Can Fite Biopharma
 20-F Annual Report

20-F Annual Report 2017-03-30

Language: English

View Annual Report (20-F)
Thumbnail Can Fite Biopharma
 20-F Annual Report

20-F Annual Report 2016-03-31

Language: English

View Annual Report (20-F)
Thumbnail Can Fite Biopharma
 20-F Annual Report

20-F Annual Report 2015-03-27

Language: English

View Annual Report (20-F)
Thumbnail Can Fite Biopharma
 20-F Annual Report

20-F Annual Report 2014-03-31

Language: English

View Annual Report (20-F)